Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Aslan Pharmaceuticals Ltd ADR
ASLNCurrent price
0.6 USD
-0.1 USD (-14.27%)
Last closed
0.6 USD
Company
aslanpharma.com
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
1 697 010 USD
Yield for 12 month
-75.41 %
1Y
3Y
5Y
10Y
15Y
ASLN
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises eblasakimab (ASLAN004), a monoclonal antibody that targets the IL-13 receptor a1 subunit which is under Phase 2 developed for the treatment of atopic dermatitis and other immunology indications; and farudodstat (ASLAN003), an orally active, potent inhibitor of human dihydroorotate dehydrogenase currently under Phase 2 clinical trials for the treatment of autoimmune diseases. It has research collaboration agreement with Zenyaku Kogyo Co., Ltd. for the development and commercialization of eblasakimab in atopic dermatitis and all other indications in Japan. The company was founded in 2010 and is headquartered in Singapore. Address: 3 Temasek Avenue, Singapore, Singapore, 039190
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
72 USDP/E ratio
–Dividend Yield
–Current Year
+12 000 000 USD
Last Year
+12 000 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+11 651 502 USD
Last Year
-331 752 USD
Current Quarter
–
Last Quarter
–
Key Figures ASLN
1 year
3 years
5 years
10 years
EBITDA
-34 893 432 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-53.69 %
PEG Ratio
–
Return On Equity TTM
-426.64 %
Wall Street Target Price
72 USD
Revenue TTM
12 000 000 USD
Book Value
-7.7 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
79 821 000 USD
Earnings per share
-16 USD
Diluted Eps TTM
-16 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-291.89 %
Dividend Analytics ASLN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ASLN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:8
Payout Ratio
–
Last Split Date
03.07.2024
Dividend Date
–
Stock Valuation ASLN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.7356
Price Sales TTM
0.9432
Enterprise Value EBITDA
-0.2158
Price Book MRQ
2.1426
Financials ASLN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ASLN
For 52 weeks
0.48 USD
20.4 USD
50 Day MA
2.8 USD
Shares Short Prior Month
269 900
200 Day MA
4.76 USD
Short Ratio
1.85
Shares Short
306 565
Short Percent
1.46 %
BeatStart